Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL

被引：17
|
作者：
Frick, Mareike [1 ,2 ,3 ]
Bettstetter, Marcus [4 ]
Bertz, Simone [5 ]
Schwarz-Furlan, Stephan [5 ,6 ]
Hartmann, Arndt [5 ]
Richter, Thomas [7 ]
Lenze, Dido [8 ]
Hummel, Michael [8 ]
Dreyling, Martin [9 ]
Lenz, Georg [10 ,11 ]
Gaumann, Andreas [6 ]
机构：
[1] Charite Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany
[3] BIH Biomed Innovat Acad, Berlin Inst Hlth BIH, Berlin, Germany
[4] Mol Pathol Sudbayern, Munich, Germany
[5] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany
[6] Klinikum Kaufbeuren, Inst Pathol, Kaufbeuren, Germany
[7] Inst Pathol, Rosenheim, Germany
[8] Charite, Dept Pathol, Berlin, Germany
[9] Univ Hosp Munich, Dept Internal Med 3, Munich, Germany
[10] Univ Hosp Munster, Dept Med A, Translat Oncol, Munster, Germany
[11] Cluster Excellence EXC 1003, Cells Mot, Munster, Germany
来源：
LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 05期
基金：
瑞士国家科学基金会;
关键词：
B-CELL LYMPHOMA; ONCOGENIC MYD88; HIGH PREVALENCE; CLASSIFICATION; SURVIVAL;
D O I：
10.1080/10428194.2017.1370546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1260 / 1263
页数：4
相关论文
共 50 条
  • [31] Clinicopathologic Significance of MYD88 L265P Mutation in Diffuse Large B-Cell Lymphoma (DLBCL)
    Talaat, Ahmed
    El-Ashwah, Shaimaa
    Tharwat, Layla
    Eladl, Ahmed
    Shamaa, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S430 - S430
  • [32] High Prevalence of MYD88 and CD79B Mutations and PD-L1 Alterations in Bone Marrow Large B Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis
    Shi, Wenyu
    Miao, Yi
    Shi, Yu
    Zhu, Huayuan
    Li, Jianyong
    BLOOD, 2023, 142
  • [33] 弥漫大B细胞淋巴瘤中MYD88、CD79B基因特征与临床病理及预后的关系
    吴灿
    张大川
    王辉
    雷婷
    史勇强
    谢雯莹
    贾晨昊
    李青
    临床与实验病理学杂志, 2022, (09) : 1072 - 1077
  • [34] Frequency and Prognostic Significance of MYD88 Mutations and MGMT Methylation in Primary Central Nervous System Diffuse Large B-Cell Lymphoma (PCNS-DLBCL)
    Zheng, M.
    Perry, A.
    Bierman, P. J.
    Nasr, M. R.
    Szwajcer, D.
    Del Bigio, M.
    Greiner, T. C.
    MODERN PATHOLOGY, 2014, 27 : 389A - 389A
  • [35] Toripalimab plus lenalidomide for central nervous system recurrence in refractory CD5+diffuse large B-cell lymphoma with MYD88 and CD79B comutation: a case report
    Chen, Xi
    Zhang, Zhihan
    Zhang, Junbao
    Yu, Qiuxiao
    Qiu, Junjing
    Xiao, Yajie
    Chen, Binbin
    Xu, Ping
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (02) : 1188 - 1195
  • [36] Frequency and Prognostic Significance of MYD88 Mutations and MGMT Methylation in Primary Central Nervous System Diffuse Large B-Cell Lymphoma (PCNS-DLBCL)
    Zheng, M.
    Perry, A.
    Bierman, P. J.
    Nasr, M. R.
    Szwajcer, D.
    Del Bigio, M.
    Greiner, T. C.
    LABORATORY INVESTIGATION, 2014, 94 : 389A - 389A
  • [37] MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma
    Aggarwal, Vaishali
    Das, Ashim
    Bal, Amanjit
    Srinivasan, Radhika
    Das, Reena
    Prakash, Gaurav
    Malhotra, Pankaj
    Varma, Subhash
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (04) : 311 - 318
  • [38] Clinical Significance of Genetic Mutations of CD79B, CARD11, MYD88, and EZH2 Genes in Diffuse Large B-Cell Lymphoma Patients
    Iriyama, Chisako
    Tomita, Akihiro
    Tokunaga, Takashi
    Sugiyama, Keisuke
    Hiraga, Junji
    Kinoshita, Tomohiro
    Naoe, Tomoki
    BLOOD, 2011, 118 (21) : 1131 - 1131
  • [39] Mivavotinib, a Syk Inhibitor, in Relapsed/Refractory (R/R) Non-GCB Diffuse Large B-Cell Lymphoma (DLBCL) with or without MYD88 and/or CD79 Mutations: A Phase 2 Study
    Karmali, Reem
    Landsburg, Daniel J.
    Westin, Jason
    Leonard, John P.
    Kuriakose, Emil T.
    Sumrow, Bradley James
    Carroll, Susheela
    Albert, Katherine
    Akella, Lalith
    Gordon, Leo, I
    BLOOD, 2022, 140 : 12125 - 12126
  • [40] Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma
    Kirkegaard, Marina Knudsen
    Minderman, Marthe
    Sjo, Lene Dissing
    Pals, Steven T.
    Eriksen, Patrick R. G.
    Heegaard, Steffen
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (04) : 576 - 581
12345